These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 1354347

  • 1. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
    Peng M, Lundgren E.
    Oncogene; 1992 Sep; 7(9):1775-82. PubMed ID: 1354347
    [Abstract] [Full Text] [Related]

  • 2. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1.
    Peng M, Lundgren E.
    Leukemia; 1993 Jan; 7(1):104-12. PubMed ID: 8093369
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E.
    J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
    [Abstract] [Full Text] [Related]

  • 4. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines.
    Floettmann JE, Ward K, Rickinson AB, Rowe M.
    Virology; 1996 Sep 01; 223(1):29-40. PubMed ID: 8806537
    [Abstract] [Full Text] [Related]

  • 5. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
    Rea D, Fourcade C, Leblond V, Rowe M, Joab I, Edelman L, Bitker MO, Gandjbakhch I, Suberbielle C, Farcet JP.
    Transplantation; 1994 Aug 15; 58(3):317-24. PubMed ID: 8053055
    [Abstract] [Full Text] [Related]

  • 6. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
    Cuomo L, Trivedi P, Wang F, Winberg G, Klein G, Masucci MG.
    Eur J Immunol; 1990 Oct 15; 20(10):2293-9. PubMed ID: 2173662
    [Abstract] [Full Text] [Related]

  • 7. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
    Cordier M, Calender A, Billaud M, Zimber U, Rousselet G, Pavlish O, Banchereau J, Tursz T, Bornkamm G, Lenoir GM.
    J Virol; 1990 Mar 15; 64(3):1002-13. PubMed ID: 2154588
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis.
    Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J, Rickinson AB.
    Nature; 1991 Feb 14; 349(6310):612-4. PubMed ID: 1705663
    [Abstract] [Full Text] [Related]

  • 11. Cell phenotype-dependent control of Epstein-Barr virus latent membrane protein 1 gene regulatory sequences.
    Fåhraeus R, Jansson A, Sjöblom A, Nilsson T, Klein G, Rymo L.
    Virology; 1993 Jul 14; 195(1):71-80. PubMed ID: 8391188
    [Abstract] [Full Text] [Related]

  • 12. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T, Sjöblom A, Masucci MG, Rymo L.
    Virology; 1993 Apr 14; 193(2):774-85. PubMed ID: 8384755
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells.
    Niedobitek G, Agathanggelou A, Herbst H, Whitehead L, Wright DH, Young LS.
    J Pathol; 1997 Jun 14; 182(2):151-9. PubMed ID: 9274524
    [Abstract] [Full Text] [Related]

  • 14. Efficient foreign gene expression in Epstein-Barr virus-transformed human B-cells.
    Curiel TJ, Cook DR, Bogedain C, Jilg W, Harrison GS, Cotten M, Curiel DT, Wagner E.
    Virology; 1994 Feb 14; 198(2):577-85. PubMed ID: 8291240
    [Abstract] [Full Text] [Related]

  • 15. Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells.
    Höfelmayr H, Strobl LJ, Marschall G, Bornkamm GW, Zimber-Strobl U.
    J Virol; 2001 Mar 14; 75(5):2033-40. PubMed ID: 11160707
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus nuclear antigen 2-estrogen receptor fusion proteins transactivate viral and cellular genes and interact with RBP-J kappa in a conditional fashion.
    Kempkes B, Pawlita M, Zimber-Strobl U, Eissner G, Laux G, Bornkamm GW.
    Virology; 1995 Dec 20; 214(2):675-9. PubMed ID: 8553575
    [Abstract] [Full Text] [Related]

  • 17. Expression of Epstein-Barr virus nuclear antigen-2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21.
    Larcher C, Kempkes B, Kremmer E, Prodinger WM, Pawlita M, Bornkamm GW, Dierich MP.
    Eur J Immunol; 1995 Jun 20; 25(6):1713-9. PubMed ID: 7614999
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.
    Young L, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson A, Kieff E.
    N Engl J Med; 1989 Oct 19; 321(16):1080-5. PubMed ID: 2552313
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context.
    Cordier-Bussat M, Billaud M, Calender A, Lenoir GM.
    Int J Cancer; 1993 Jan 02; 53(1):153-60. PubMed ID: 8416201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.